Fintel reports that on November 4, 2025, Citigroup maintained coverage of Krystal Biotech (NasdaqGS:KRYS) with a Neutral ...

Fintel reports that on November 4, 2025, Chardan Capital maintained coverage of Krystal Biotech (NasdaqGS:KRYS) with a Buy ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

Colossal Biosciences, which has brought to life a small pack of genetically modified dire wolves, has acquired cloning ...

NFL star Tom Brady has cloned his late pit bull mix, Lua, creating a new dog named Junie. Invested in biotech firm Colossal ...

Portfolio manager Eden Rahim sees biotech entering a new bull market amid lower rates, better trial data and renewed investor ...

Less than two years after emerging, Arena BioWorks is shuttering, citing the “adverse impact of biotech macro conditions” as ...

Tom Brady says his dog is a clone. The six-time Super Bowl-winning quarterback and current Fox Sports broadcaster said ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in October 2025.

Ionis Pharmaceuticals, Inc. shows promise with new drug launches and a robust pipeline. Click here to read IONS stock ...

A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.